Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (39)

2022

  1. Hypothyroidism confers tolerance to cerebral malaria

    Science advances, Vol. 8, Núm. 14, pp. eabj7110

  2. TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy

    Neurobiology of Disease, Vol. 165

2021

  1. Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation

    Molecular Psychiatry, Vol. 26, Núm. 11, pp. 6411-6426

2020

  1. Differential regulation of Kidins220 isoforms in Huntington's disease

    Brain Pathology, Vol. 30, Núm. 1, pp. 120-136

2019

  1. Amyloid peptide induced neuroinflammation increases the P2X7 receptor expression in microglial cells, impacting on its functionality

    Frontiers in Cellular Neuroscience, Vol. 13

2018

  1. Erratum: Author Correction: Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1 (Nature communications (2017) 8 1 (2275))

    Nature communications

  2. Haploinsufficient TNAP mice display decreased extracellular ATP levels and expression of Pannexin-1 channels

    Frontiers in Pharmacology, Vol. 9, Núm. MAR

  3. MicroRNA-22 controls aberrant neurogenesis and changes in neuronal morphology after status epilepticus

    Frontiers in Molecular Neuroscience, Vol. 11

  4. The regulation of proteostasis in glial cells by nucleotide receptors is key in acute neuroinflammation

    FASEB Journal, Vol. 32, Núm. 6, pp. 3020-3032

2016

  1. Protein degradation in a LAMP-2-deficient B-lymphoblastoid cell line from a patient with Danon disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 8, pp. 1423-1432

2015

  1. Tissue-nonspecific Alkaline Phosphatase Regulates Purinergic Transmission in the Central Nervous System during Development and Disease

    Computational and Structural Biotechnology Journal, Vol. 13, pp. 95-100

2014

  1. Epitope mapping of antibodies to alpha-synuclein in LRRK2 mutation carriers, idiopathic parkinson disease patients, and healthy controls

    Frontiers in Aging Neuroscience, Vol. 6, Núm. JUL

2013

  1. P2X receptors as targets for the treatment of status epilepticus

    Frontiers in Cellular Neuroscience, Vol. 7, Núm. NOV

2012

  1. A critical appraisal of quantitative studies of protein degradation in the framework of cellular proteostasis

    Biochemistry Research International

  2. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation

    Journal of Cell Science, Vol. 125, Núm. 1, pp. 176-188

  3. Tau overexpression results in its secretion via membrane vesicles

    Neurodegenerative Diseases, Vol. 10, Núm. 1-4, pp. 73-75

  4. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

    Human Molecular Genetics, Vol. 21, Núm. 3, pp. 495-510

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

2010

  1. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation

    Journal of Neuroscience, Vol. 30, Núm. 10, pp. 3675-3688

  2. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum

    Cell Death and Differentiation, Vol. 17, Núm. 2, pp. 324-335